back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-06-27 11:59 Tx date 2019-06-24 |
$DMA
DiaMedica Therapeutics Inc. |
Verdoorn, Todd
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+71,025 vol |
1,650,525 | |
| Filed 2018-12-11 Tx date 2018-12-11 |
$DMA
DiaMedica Therapeutics Inc. |
Verdoorn, Todd
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
+1,000 vol |
21,000 | |
| Filed 2018-08-02 Tx date 2018-07-31 |
$DMA
DiaMedica Therapeutics Inc. |
Verdoorn, Todd
5 - Senior Officer of Issuer
Holder: Patricia Verdoorn (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,500
+10,000 vol $0.45 each |
10,000 | |
| Filed 2018-08-02 Tx date 2016-05-09 |
$DMA
DiaMedica Therapeutics Inc. |
Verdoorn, Todd
5 - Senior Officer of Issuer
Holder: Patricia Verdoorn (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-02 Tx date 2018-08-01 |
$DMA
DiaMedica Therapeutics Inc. |
Verdoorn, Todd
5 - Senior Officer of Issuer
Holder: Patricia Verdoorn (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,560
+10,000 vol $0.456 each |
20,000 | |
| Filed 2018-07-12 Tx date 2018-04-17 |
$DMA
DiaMedica Therapeutics Inc. |
Verdoorn, Todd
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$243,880
+435,500 vol $0.56 each |
1,579,500 | |
| Filed 2017-06-23 Tx date 2017-06-19 |
$DMA
DiaMedica Therapeutics Inc. |
Verdoorn, Todd
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
1,144,000 | |
| Filed 2017-02-14 Tx date 2017-01-18 |
$DMA
DiaMedica Therapeutics Inc. |
Verdoorn, Todd
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,600
+20,000 vol $0.13 each |
20,000 | |
| Filed 2017-02-14 Tx date 2016-05-09 |
$DMA
DiaMedica Therapeutics Inc. |
Verdoorn, Todd
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-02 Tx date 2016-05-09 |
$DMA
DiaMedica Inc. |
Verdoorn, Todd
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
144,000 | ||
| Filed 2016-12-02 Tx date 2016-11-28 |
$DMA
DiaMedica Inc. |
Verdoorn, Todd
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
644,000 |